To date, there are no HER2-particular targeted therapies approved for sufferers with amplification, nor is there enough data to suggest whether these sufferers would reap … Continue reading To date, there are no HER2-particular targeted therapies approved for sufferers with amplification, nor is there enough data to suggest whether these sufferers would reap the benefits of HER2-targeted therapies